NCT05006937

Brief Summary

The purpose of this study is to determine the differences in stone free results, patient side effects, and patient satisfaction between dusting vs. basket extraction for kidney and ureteral stones (a kidney stone located in the tube between the kidney and bladder) 6 mm and greater in size undergoing ureteroscopic treatment. Dusting is when a laser is used to break a stone down into tiny fragments that are able to pass through the urine. Basket extraction is when a small wire basket is used to remove stone fragments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 28, 2021

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

August 6, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 16, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2024

Completed
Last Updated

April 30, 2026

Status Verified

July 1, 2025

Enrollment Period

1.9 years

First QC Date

August 6, 2021

Last Update Submit

April 26, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Stone free rate: clinical

    patients with no clinical evidence of kidney stones on the treated side

    6 weeks

  • Stone free rate: imaging

    patients with no radiographic evidence of kidney stones on the treated side

    6 weeks

Secondary Outcomes (4)

  • Patient quality of life- pain intensity

    12 weeks

  • Patient quality of life- pain interference

    12 weeks

  • Return to work

    12 weeks

  • Daily activity level

    12 weeks

Study Arms (2)

laser dusting

ACTIVE COMPARATOR

In the "dusting" arm, the ureteroscope will be advanced into the kidney or ureter over an access wire without an access sheath in place. The identified stone will be dusted using a 200 micron Moses laser fiber at a setting of 0.3-0.6 J and 50-120 Hz using the Moses 2.0 laser system. Stone dusting will continue until the surgeon feels the fragments are all negligible in size and would be able to pass. One small piece will be extracted for analysis and the remainder will be left to pass spontaneously. If there is no evidence of injury or swelling of the ureter at the conclusion of the case a stent will be omitted.

Procedure: Dusting

basketing

ACTIVE COMPARATOR

In the Basketing arm, a ureteral access sheath (UAS) will be placed per standard fashion. The ureteroscope will be introduced into the kidney and the stone fragmented at a setting of 0.8-1.0 J and 6-15 Hz. The resultant fragments will be basket extracted through the sheath for analysis. All fragments will be removed until no residual stone remains. At the time of UAS removal the ureter will be inspected. If there is no evidence of ureteral injury or swelling then a stent will be omitted.

Procedure: Basket extraction

Interventions

DustingPROCEDURE

Dusting is when a laser is used to break a stone down into tiny fragments that are able to pass through the urine.

laser dusting

Basket extraction is when a small wire basket is used to remove stone fragments.

basketing

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>18 years of age
  • undergoing ureteroscopic stone extraction
  • Stone size 6mm stones or greater and the location to mid ureter or higher
  • Willing to sign informed consent form
  • Able to read, understand, and complete patient questionnaires, and pain questionnaires

You may not qualify if:

  • \< 18 years of age
  • Inability to provide informed consent
  • Concomitant surgery (i.e. Percutaneous nephrolithotomy, Holmium laser enucleation of the prostate
  • Solitary kidney
  • Nephrocalcinosis
  • Members of vulnerable patient populations
  • Patients without access to a phone that can receive txt messages

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern Memorial Hospital

Chicago, Illinois, 60611, United States

Location

MeSH Terms

Conditions

Kidney CalculiUreterolithiasis

Interventions

Dust

Condition Hierarchy (Ancestors)

NephrolithiasisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisUrinary CalculiMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsUreteral Diseases

Intervention Hierarchy (Ancestors)

Particulate MatterComplex Mixtures

Study Officials

  • Amy Krambeck, MD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Urology

Study Record Dates

First Submitted

August 6, 2021

First Posted

August 16, 2021

Study Start

July 28, 2021

Primary Completion

July 1, 2023

Study Completion

June 10, 2024

Last Updated

April 30, 2026

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations